Grifols In Talks For $5B Stake In China's Shanghai RAAS Blood Products By: TalkMarkets November 23, 2018 at 11:30 AM EST Grifols would invest in Shanghai RAAS by means of the contribution of its fully owned U.S. subsidiary, Grifols Diagnostic Solutions. Read More >> Related Stocks: Grifols S.A. ADR